Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
3.216
Zitationen
16
Autoren
2004
Jahr
Abstract
Among high-risk patients with resected head and neck cancer, concurrent postoperative chemotherapy and radiotherapy significantly improve the rates of local and regional control and disease-free survival. However, the combined treatment is associated with a substantial increase in adverse effects.
Ähnliche Arbeiten
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
1993 · 15.649 Zit.
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 · 6.411 Zit.
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 · 5.076 Zit.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
2016 · 4.947 Zit.
Head and neck squamous cell carcinoma
2020 · 3.834 Zit.
Autoren
Institutionen
- Columbia University Irving Medical Center(US)
- New York University(US)
- RTOG Foundation(US)
- Wayne State University(US)
- Medical College of Wisconsin(US)
- National Cancer Institute(MY)
- Moffitt Cancer Center(US)
- State University of New York(US)
- University of Pennsylvania Health System(US)
- Mallinckrodt (Ireland)(IE)
- University of California, San Francisco(US)